Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease.
Phillip GuAnshika KapurDalin LiTalin HarituniansEric VasiliauskasDavid Q ShihStephan R TarganBrennan Mr SpiegelDermot Pb McgovernJeanne T BlackGil Y MelmedPublished in: Journal of digestive diseases (2018)
In patients with IBD who required at least one emergency department visit or hospitalization, anti-CBir1 antibody status may be a useful biomarker of HRU when formulating management strategies to reduce disease complications and resource utilization.